Mohammed Alhatou

Mohammed Alhatou

Hamad Medical Corporation - Doha / Qatar
Others
AD Scientific Index ID: 4698734
person_outline Mohammed Alhatou's MOST POPULAR ARTICLES
1-) Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial RL Sacco, JT DeRosa, EC Haley Jr, B Levin, P Ordronneau, SJ Phillips, ... Jama 285 (13), 1719-1728, 2001 3302001
2-) Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trialP Khatri, DO Kleindorfer, T Devlin, RN Sawyer, M Starr, J Mejilla, ...Jama 320 (2), 156-166, 20182532018
3-) Transient ischemic attack and stroke associated with sildenafil (Viagra) useJC Morgan, M Alhatou, J Oberlies, KC JohnstonNeurology 57 (9), 1730-1731, 2001842001
4-) Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: a multicentre open-label trialWW Zadeh, A Escartin, W Byrnes, F Tennigkeit, S Borghs, T Li, ...Seizure 31, 72-79, 2015502015
5-) Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathologyMI Alhatou, JT Sladky, O Bagasra, JD GlassJournal of molecular histology 35, 615-619, 2004452004